Clinical Trial Update: Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing cyclosporine with infliximab for steroid-refractory severe ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Remicade (infliximab)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Ulcerative Colitis, Steroid Refractory | Phase 4 | Status: COMPLETED